Once-Weekly Semaglutide in Adults with Overweight or Obesity
WEBFeb 10, 2021 · Our trial showed that among adults with overweight or obesity (without diabetes), once-weekly subcutaneous semaglutide plus lifestyle intervention was associated with substantial, sustained ...
The New England Journal of Medicine | Research & Review Articles …
WEBThe New England Journal of Medicine (NEJM) is a weekly general medical journal that publishes new medical research and review articles, and editorial opinion on a wide variety of topics of ...
Effect of Early Treatment with Ivermectin among Patients with …
WEBMar 30, 2022 · One drug that has received considerable public use and interest is ivermectin, which is typically used as an antiparasitic drug. Ivermectin inhibits the chloride channels of helminthic parasites ...
Coronavirus (Covid-19) | NEJM - The New England Journal of …
WEBExplore a collection of articles and other resources on the Coronavirus (Covid-19) outbreak, including clinical reports, management guidelines, and commentary.
Tirzepatide versus Semaglutide Once Weekly in Patients with Type …
WEBJun 25, 2021 · Tirzepatide is a dual glucose-dependent insulinotropic polypeptide–GLP-1 receptor agonist. Its structure is primarily based on the glucose-dependent insulinotropic polypeptide amino acid ...
Tirzepatide Once Weekly for the Treatment of Obesity
WEBJun 4, 2022 · Tirzepatide is a once-weekly subcutaneous injectable peptide (approved by the Food and Drug Administration [FDA] for type 2 diabetes) engineered from the native GIP sequence, with agonist activity ...
Toxic Effects from Ivermectin Use Associated with Prevention and ...
WEBOct 20, 2021 · The Oregon Poison Center received calls at a rate of 0.25 per month in all of 2020, as compared with 21 calls in August 2021 alone, regarding toxic effects from ivermectin in persons who used the d...
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
WEBDec 10, 2020 · Discussion. A two-dose regimen of BNT162b2 (30 μg per dose, given 21 days apart) was found to be safe and 95% effective against Covid-19. The vaccine met both primary efficacy end points, with ...
Pulmonary Embolism | New England Journal of Medicine
WEBJul 6, 2022 · Pulmonary Embolism. •. Pulmonary embolism is a common diagnosis and can be associated with recurrent venous thromboembolism, bleeding due to anticoagulant therapy, chronic thromboembolic ...
The Origins of Covid-19 — Why It Matters (and Why It Doesn’t)
WEBJun 7, 2023 · Key Events in the Effort to Determine the Origins of the Covid-19 Pandemic. The joint WHO–China technical report published in March 2021 rated a zoonotic spillover as a “likely to very likely ...